Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Durvalumab
Durvalumab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
IMFINZI 50 mg/mL concentrate for solution for infusion
Updated
SPC
PIL
No
A
Durvalumab
AstraZeneca Pharmaceuticals (Ireland) DAC
Cookies